studyfinds

The agency said that two doses of both the Oxford/AstraZeneca and Pfizer/BioNtech vaccines provide “much lower levels” of protection against symptomatic infection. A third booster dose of COVID-19 vaccine provides 70-75 per cent protection…

The findings, reported by Project: Jeevan Raksha, found that underreporting of pandemic-linked deaths in Gujarat was a staggering 5,722%. (File)Covid-19 deaths in Gujarat were massively under-reported, lending credence to claims during the…

Doctors suggest seeking medical advice if the reading dips below 94. (Pixabay via IE)New research from South Africa has found that using pulse oximeters to check oxygen saturation levels following a Covid-19 diagnosis saves lives. The…

The team studied several people who had undergone liver transplants since 2006, including those suffering from by Covid-19Covid-19 did not have a negative impact on people with uncomplicated liver transplants and no co-morbid conditions, a…

University of Oxford and Office for National Statistics researchers conducted the study, the results of which were published in a pre-printThe effectiveness of Oxford-AstraZeneca and Pfizer-BioNTech vaccines against the Delta variant of the…

Higher antibody levels over a period of time were also associated with persistent symptomsPeople with severe or long-lasting Covid-19 symptoms are more likely to develop high antibody levels needed to fight future infections, a new Rutgers…

The AY.1 (Delta Plus), a highly infectious variant first detected in April in India, has subsequently been detected in 20 other countriesBharat Biotech’s Covaxin is effective against the Delta Plus variant of the coronavirus despite…